Carvedilol: A beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats

Life Sciences

Volumn 66, Issue 26, 2000, Pages 2603-2611

  Kumar, K Vijay ^a   Shifow, Anwar A ^a   Naidu, M U R ^a   Ratnakar, K S ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antioxidant; Carvedilol; Gentamicin induced nephrotoxicity

Indexed keywords

CARVEDILOL; CREATININE; GENTAMICIN; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFICACY; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; UREA BLOOD LEVEL;

ANIMALIA; NEGIBACTERIA;

EID: 0034685751     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00594-4     Document Type: Article

References (64)

1. 1. H.D. Humes and J.M. Weinberg. Toxic Nephropathies, In: Kidney: BM. Brenner; F.E. Rector (Jr) (Eds) 1491-1453, Saunders Co., Philadelphia, (1986).
2. 2. J.M. Eisenberg, H. Koffer, R.A. Glick, M.L. Cornvell and et al. Ann. Intern. Med. 107 900-909 (1997).
3. 3. R.B. Fox. J Clin Invest. 74 1456-1467 (1984).
4. 4. P.M. Whiting and P.A. Brown. Ren. Fail. 18 899-909 (1996).
5. 5. M. Cheng, M.S. Razzaque, A. Nazneen and T. Taguchi. Int. J. Exp. Pathol. 79 125-132 (1988)
6. 6. A. Rodriquez-Barbero, J.M. Lopez-Novoa and M. Arevalo. Exp Nephrol. 5 47-54 (1997).
7. 7. L.S. Ramasammy, C. Josephowitz, K.Y. Ling, B.P. Lane and G.J. Kaloyanides. J Pharma. Exp. Ther. 238 83-88 (1986).
8. 8. P.D. Walker and S.V. Shah. Am. J. Physiol. 53 495-499 (1987).
9. 9. X.H. Du and C.L. Yang. Nephrol. Dial. Transplant. 9 135-140 (1994)
10. 10. P.D. Walker, Y. Barri and S.V. Shah. Ren. Failure. 21 433-443 (1999).
11. 11. S.V. Shah. J Clin Invest. 74 393-401 (1984).
12. 12. S.V. Shah, W.H. Barcos and A. Basci. J Clin Invest 79 25-31 (1987).
13. 13. A.K. Rehan, R.C. Wiggins, R.G. Kunkel, G.O. Till and K.H. Johnson. Am J Pathol. 123 57-66 (1986).
14. 14. A.K. Rehan, K.J. Johnson, R.G. Kunkel and R.C. Wiggins. Kidney Int. 7 503-511, (1985).
15. 15. L.S. Ramasammy, K.Y. Ling, C. Josephowitz, R. Levine and G.J. Kaloyanides. Biochem. Pharmacol. 34 3895-3899 (1985).
16. 16. A.K. Salahudeen, E.L. Clark and K.A. Nath. J Clin. Invest. 199 1886-1893 (1991).
17. 17. T. Yoshioka, T. Bills, T. Moore-Jarrett, H.L. Green, M. Burr and I. Ichiwaka. Kidney Intern. 38 282-288 (1990)
18. 18. B.R. Guidet and S.V. Shah. Am. J. Physiol. 256 F158-F164 (1989).
19. 19. M.U.R. Naidu, K. Vijay Kumar, Anwar Ahmed Shifow, Aruna Prayag and K.S. Ratnakar. Nephron. 81 60-66 (2000).
20. 20. K. Vijay Kumar, M.U.R. Naidu, Anwar Ahmed Shifow, Aruna Prayag and K.S. Ratnakar. Transplantation. 67 1065-1068 (1999).
21. 21. P. Sandhya, S. Mohan Das and P. Varalakshmi. Mol and Cell Biol. 145 11-17 1995.
22. 22. T.L. Yue, H.Y. Cheng, P.G. Lysko, P.J. Mckenna, R.Feurestein, J.L. Gin, K.A. Lysko, L.L. Davis and G. Feuerstein. J Pharmacol. Exp. Ther. 263 92-98 (1992).
23. 23. T.L. Yue, P.J. Mckenna, P.G. Lysko, R.R. Ruffolo Jr and G. Feurerstein. Eur. J Pharmacol. 214 277-280 (1992).
24. 24. A.K. Dhalla, N. Singhal and P.K. Singhal. Circulation. 90 (suppl):491(Abs) (1994).
25. 25. G.Z. Feuerstein and R.R. Ruffolo Jr. Eur Heart J. 17(Suppl B) 24-29 (1996).
26. 26. T.L. Yue, P.J. Mckenna, J.L. Gu, H.Y. Cheng, R.R. Ruffolo Jr and G.Z. Feuerstein. Hypertension. 22 922-928 (1993).
27. 27. A.A. Abdul-Gayom, B.H. Ali, K.M. Abdel Razig, A.A. Bashir and Ghywarsha. Arch Toxicol. 68 643-674 (1994).
28. 28. A.K. Butler. Clin. Chem. Acta. 59 227-230 (1975).
29. 29. F.M. Bernheim, B.L. Bernheim and K.M. Wilbur. J Biol Chem, 174 257-264 (1948).
30. 30. O.H. Lowry, N.J. Rosenbrough, A.L. Farr and R.J. Randall. J Biol. Chem. 193 265-275 (1955).
31. 31. D.C. Houghton, C.E. Plamp, J.M. Defehr, W.M. Bennet, G. Forter and D. Gilbert. Am J Pathol. 93 137-152 (1978).
32. 32. P.D. Walker and S.V. Shah. J Clin. Invest. 81 334-341 (1988)
33. 33. B.H. Ali, A.A. Abdel Gayoum and A.A. Bashir. Pharmacology & Toxicology. 70 419-423 (1992).
34. 34. R.E. Cronin, R.E. Bulger, P. Southern and W.L. Henrich. J Lab. Clin Med. 95 463-474 (1980).
35. 35. D.N. Gilbert, C.A. Wood, P.W. Kohlepp, D.C. Houghton, H.C. Finkbeiner, J. Lindsley and W.M. Bennet. J Infect Dis. 159 945-953 (1989).
36. 36. S. Kacew. J Pharmacol Exp Ther. 248 360-367 (1989).
37. 37. L.S. Ramasammy, C. Josepovitz, K.Y. Ling, B.P. Lane and G.J. Kaloyanides. J Pharmacol. Exp Ther. 238 83-88 (1986).
38. 38. A. Oshnishi, T.D. Biryant, K.R. Branch, R. Sabra and R.A. Branch. Antimicrob. Agents Chemother. 33 928-932 (1989).
39. 39. N.L. Wong, A.B. Magil and J.H. Dirks. Nephron. 51 84-88 (1989).
40. 40. K. Uekama, K. Shiotami, T. Iric, Y. Ishimaru and J. Pitha. J Pharma. Pharmacol. 45 745-747(1993).
41. 41. T. Hayashi, Y. Watanbe, K. Kumano, R. Kitayama, R.T. Yasuda, I. Saikawa, J. Katahira, T. Kumada and K. Shimazu. Antimicro Agents Chemother. 3 912-918 (1988).
42. 42. B. Chance, H. Sies and A. Boveris. Physiol. Rev. 59 527-530 (1979)
43. 43. R.F. Del Maestro. Acta Physiol. Scan. 492 153-159 (1980)
44. 44. J. Varani, S.E. Fliegel, G.O. Till, R.G. Kunkel, U.S. Ryan and P.A. Ward. Lab Invest. 53 656-663 (1985).
45. 45. J.J. Weiss and A.F. Lubuglio, Lab Invest. 47 5-18 (1982).
46. 46. L.S. Ramasammy, C. Josepovitz, K.Y. Ling, B.P. Lane and G.J. Kaloynides. Biochem Pharmacol. 36 2125-2132 (1987).
47. 47. M. Washio, F. Nanishi, K. Onoyama and M. Fujishima. Nephron. 68 347-352 (1994).
48. 48. T. Okasaro, T. Takikawa and T. Utisumiya. Nephron. 60 199-203 (1992).
49. 49. A.L. Tappel. Fedn Proc. 24 73-77 (1965).
50. 50. M.M. Gilbert, J. Sprecher, L.W. Chang and L.F. Meisner. J Toxic. Environ. Hlth. 12 767-771 (1983).
51. 51. G. Van Den Branden, R. Verelst, J. Vameca, K. Vanden Houte and D. Verbeelan. Nephron. 76 77-81 (1997).
52. 52. M. Gellai, R. Dewolf and R.R. Ruffolo Jr. Pharmacology. 41 200-206 (1990).
53. 53. R.R. Ruffolo Jr, D.A. Boyle, D.P. Brooks and et al. Cardiovasc Drug Rev. 10 127-157 (1992).
54. 54. D.P. Brooks, B.G. Shor, M.J. Cryonak and et al. Br J Pharmacol. 109 581-586 (1993)
55. 55. A.G. Dupont. Clin Invest. 70 S127-S131 (1992).
56. 56. T.L. Yue, T. Liu and G. Feurestien. Pharmacol Commun. 1 27-35 (1992).
57. 57. T.L. Yue, P.J. Mckenna, P.G. Lysko and et al. Eur. J Pharmacol. 251 237-243 (1994).
58. 58. R. Feuerstein and T.L. Yue. Pharmacology. 48 385-391 (1994).
59. 59. T.L. Yue, P.J. Mckenna, P.G. Lysko, R.R. Ruffolo Jr and G.Z. Feurestein. Atherosclerosis. 97 209-216 (1992).
60. 60. T.L. Yue, P.G. Lysko, F.C. Barone, J.L. Gu, R.R. Ruffolo Jr and G. Feurestein. NY Acad Sci. 738 230-242 (1994).
61. 61. Van Den Branden, M. Gabriels, J. Vamela, K. Vanhoute and D. Verbeelan. Nephron. 77 319-324 (1997).
62. 62. B.H. Ali and A.K. Bashir. Gen Pharmaol. 27 349-353 (1996).
63. 63. Anwar A. Shifow, K. Vijay Kumar, M.U.R. Naidu and K.S. Ratnakar. Nephron, in press (2000)
64. 64. M. Nakakuki, F. Yamasaki, T. Shinkawa, M. Kuda, M. Watanbe and M. Mizota. Can J Phys and Pharmacol. 74 104-111 (1996)